Journal
NEUROLOGICAL RESEARCH
Volume 40, Issue 8, Pages 702-708Publisher
TAYLOR & FRANCIS LTD
DOI: 10.1080/01616412.2018.1463900
Keywords
Bexarotene; subarachnoid hemorrhage; early brain injury; inflammation; cell death
Categories
Ask authors/readers for more resources
Objectives: Early brain injury (EBI) is considered to be one of the main causes of poor outcome in subarachnoid hemorrhage (SAH) patients. Bexarotene is an agonist of retinoid X receptor and plays a protective role in central nervous system diseases. However, the exact role of bexarotene in SAH has not been reported. Therefore, the present study was to determine whether bexarotene administration attenuate EBI after SAH in mice and to explore the underlying mechanism. Methods: SAH was induced in C57BL/6 mice by endovascular perforation. Bexarotene was administrated intraperitoneally. Neurological score, cell death, microglia activation, and pro-inflammatory cytokines were detected at 24h after SAH. The expression of PPAR gamma was measured by Western blot. Results: Results showed that bexarotene significantly improved neurological score after SAH. In addition, the number of cell death and activated microglia were significantly reduced by bexarotene administration. Compared with vehicle-treated mice, bexarotene-treated mice showed reduced pro-inflammatory cytokines after SAH. The expression of PPAR gamma was significantly increased with bexarotene treatment compared with vehicle-treated controls. Discussion: The present study demonstrats that bexarotene administration protects against EBI after SAH, inhibiting cell death, attenuating microglia activation, and alleviating neuroinflammation. The underlying mechanism may partially involve the activation of PPAR gamma.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available